Publication date: Available online 27 March 2017
Source:Journal of Voice
Author(s): Abdul-Latif Hamdan, Georges Tabet, Ghina Fakhri, Doja Sarieddine, Rachel Btaiche, Muhieddine Seoud
ObjectiveThis study aimed to investigate the effect of hormonal therapy (HRT) on voice in a group of menopausal women, taking into consideration body mass index (BMI) as a confounding factor and its potential role as a substitute for HRT.Subjects and MethodsA total of 53 menopausal women, 34 not on HRT and 19 on HRT, were recruited. Demographic variables included age, gender, smoking, and BMI. All subjects were asked about the presence or absence of the following symptoms: hoarseness, deepening of the voice, pitch breaks, throat clearing, dryness in the throat, and vocal fatigue. Acoustic analysis was performed, and Voice Handicap Index-10 was also completed.ResultsThe mean BMI was 25.90 ± 5.39 and 25.77 ± 4.26 in patients on HRT and not on HRT, respectively. There was no statistical difference in the Voice Handicap Index-10 score and the prevalence of any of the phonatory symptoms in menopausal women not on HRT compared with menopausal women on HRT. However, menopausal women not on HRT had significantly lower habitual pitch than those on HRT (P value of 0.022). On the other hand, the jitter was significantly higher in those on HRT (P value of 0.033).ConclusionHormonal therapy has an impact on the habitual pith in menopausal women with comparable BMI. Those on HRT have a higher habitual pitch than those not on HRT.
from #Audiology via xlomafota13 on Inoreader http://ift.tt/2nboVjS
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου